Stay updated on Study of ZX008 Oral Solution in Dravet Syndrome Clinical Trial
Sign up to get notified when there's something new on the Study of ZX008 Oral Solution in Dravet Syndrome Clinical Trial page.

Latest updates to the Study of ZX008 Oral Solution in Dravet Syndrome Clinical Trial page
- Check5 days agoChange DetectedUpdated the page from Revision: v3.0.1 to v3.0.2, indicating a new release. The 'Back to Top' element was removed as a minor UI cleanup.SummaryDifference0.2%
- Check13 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%
- Check20 days agoChange DetectedThe web page has been updated to include new drug information for Fenfluramine and resources related to Dravet syndrome, while removing previous references to Fenfluramine hydrochloride and CDKL5 Deficiency Disorder. Additionally, the facility name and location details have been revised.SummaryDifference4%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.1%
- Check41 days agoChange DetectedThe web page has been updated from version v2.16.10 to v2.16.11, indicating a revision in the content.SummaryDifference0.1%
- Check48 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference1%
Stay in the know with updates to Study of ZX008 Oral Solution in Dravet Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Study of ZX008 Oral Solution in Dravet Syndrome Clinical Trial page.